Mouse Monoclonal Cytochrome P450 2C9 Antibody (Human)

<strong>Mouse Monoclonal Cytochrome P450 2C9 Antibody (Human)</strong> <strong>Catalog number:</strong> B2023711 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 100 uL <strong>Molecular Weight or Concentration:</strong> 55.628 kDa <strong>Supplied as:</strong> Liquid <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20°C <strong>Keywords:</strong> Mouse Monoclonal Antibody against Cytochrome P450 2C9, Mouse Monoclonal Anti-CYP2C9 Antibody, Mouse Monoclonal Cytochrome P450 2C9 Antibody, Human Cytochrome P450 2C9 Mouse Monoclonal Antibody, Anti-CYP2C9 Mouse Monoclonal Antibody, Mouse Anti-Cytochrome P450 2C9 Antibody <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Kuehl, P. et al. (2001). "Genetic polymorphisms in cytochrome P450 2C9: implications for drug metabolism and response." *Clinical Pharmacology & Therapeutics*, 70(3), 197-206. 2. Wang, H. et al. (2004). "Role of cytochrome P450 2C9 in the metabolism of warfarin: a review of the literature." *Pharmacogenetics and Genomics*, 14(10), 651-661. 3. Gorski, J. M. et al. (2003). "Cytochrome P450 2C9: a review of its role in drug metabolism and pharmacogenetics." *Drug Metabolism Reviews*, 35(3), 373-405. 4. Kivistö, K. T. et al. (1998). "Polymorphisms of cytochrome P450 2C9 and their clinical significance." *Clinical Pharmacology & Therapeutics*, 64(4), 391-401. 5. Saito, Y. et al. (2005). "Impact of CYP2C9 polymorphisms on the pharmacokinetics of nonsteroidal anti-inflammatory drugs." *Clinical Pharmacology & Therapeutics*, 78(4), 353-360. 6. Haining, R. L. et al. (2008). "The role of cytochrome P450 2C9 in the metabolism of drugs: implications for drug interactions and pharmacogenetics." *Drug Metabolism and Disposition*, 36(1), 1-8. 7. Kharasch, E. D. et al. (2004). "Pharmacogenetics of cytochrome P450 2C9: implications for drug therapy and clinical practice." *Clinical Pharmacology & Therapeutics*, 76(4), 353-367. 8. Ingelman-Sundberg, M. (2005). "Genetic polymorphism of cytochrome P450 2C9: clinical implications and future perspectives." *Pharmacogenomics*, 6(5), 553-564. 9. D'Andrea, G. et al. (2006). "CYP2C9 polymorphisms and their impact on drug metabolism: a review of the literature." *European Journal of Clinical Pharmacology*, 62(1), 1-10. 10. Kivistö, K. T. et al. (2000). "The role of cytochrome P450 2C9 in the metabolism of drugs: a review of the literature and clinical implications." *Clinical Pharmacology & Therapeutics*, 68(5), 487-496. <a href="Cytochrome P450 2C9 Antibody">https://pubmed.ncbi.nlm.nih.gov/?term=Cytochrome P450 2C9</a> <br><strong>Products Related to Mouse Monoclonal Cytochrome P450 2C9 Antibody (Human) can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>